Moreover, NLRP3 inflammasome blockade by MCC950 could reduce self-renewal capacity along with downregulated expression of BMI1, ALDH1 and CD44 in SCCHN cell lines. Here, ALDH1A1 is linked to head and neck squamous cell carcinoma.